Related Experiment Video
Updated: Apr 26, 2026
Primary Microglia Isolation from Mixed Glial Cell Cultures of Neonatal Rat Brain Tissue
Published on: August 15, 2012
Punicalagin inhibits neuroinflammation in LPS-activated rat primary microglia
Olumayokun A Olajide1, Asit Kumar, Ravikanth Velagapudi
1Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield, UK.
Scope:
In this study, the effects of punicalagin on neuroinflammation in LPS-activated microglia were investigated.
Methods And Results:
The ability of punicalagin to reduce the production of TNF-α, IL-6 and prostaglandin E2 was measured in culture medium using enzyme immunoassay. TNF-α and IL-6 gene expression in mouse hippocampal slices was measured with PCR. cyclooxygenase-2 and microsomal prostaglandin E synthase 1 protein and mRNA were evaluated with Western blotting and PCR, respectively. Further experiments to investigate effects of punicalagin on protein expressions of inflammatory targets were also determined with Western blotting. Pretreatment of rat primary microglia with punicalagin (5-40 μM) prior to LPS (10 ng/mL) stimulation produced a significant (p < 0.05) inhibition of TNF-α, IL-6 and prostaglandin E2 production. Punicalagin completely abolished TNF-α and IL-6 gene expression in LPS-stimulated hippocampal slices. Protein and mRNA expressions of cyclooxygenase-2 and microsomal prostaglandin E synthase 1 were also reduced by punicalagin pretreatment. Results show that punicalagin interferes with NF-κB signalling through attenuation of NF-κB-driven luciferase expression, as well as inhibition of IκB phosphorylation and nuclear translocation of p65 subunit in the microglia.
Conclusion:
These results suggest that punicalagin inhibits neuroinflammation in LPS-activated microglia through interference with NF-κB signalling, suggesting its potential as a nutritional preventive strategy in neurodegenerative disorders.
Insights
Punicalagin effectively reduces neuroinflammation in activated microglia by inhibiting key inflammatory markers and NF-κB signaling. This suggests punicalagin
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Neuroinflammation plays a critical role in the pathogenesis of neurodegenerative disorders.
- Microglia are key immune cells in the central nervous system, and their activation contributes to neuroinflammation.
- Identifying natural compounds that can modulate microglial activation is crucial for developing preventive strategies.
Purpose of the Study:
- To investigate the effects of punicalagin, a polyphenol from pomegranate, on lipopolysaccharide (LPS)-activated microglia.
- To elucidate the underlying molecular mechanisms by which punicalagin modulates neuroinflammation.
Main Methods:
- Primary rat microglia and mouse hippocampal slices were stimulated with LPS.
- Punicalagin's effects on the production of tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and prostaglandin E2 were measured.
- Gene and protein expression of inflammatory mediators (COX-2, MPGE-S1) and NF-κB signaling pathway components were analyzed using PCR, Western blotting, and luciferase assays.
Main Results:
- Punicalagin significantly inhibited the production of TNF-α, IL-6, and prostaglandin E2 in LPS-activated microglia.
- Punicalagin treatment reduced TNF-α and IL-6 gene expression in hippocampal slices.
- Punicalagin attenuated NF-κB signaling by inhibiting IκB phosphorylation and p65 nuclear translocation.
Conclusions:
- Punicalagin demonstrates potent anti-neuroinflammatory effects in LPS-activated microglia.
- The mechanism involves the interference with NF-κB signaling pathway.
- Punicalagin holds potential as a nutritional preventive strategy for neurodegenerative diseases.
